Guangdong Zhongsheng Pharmaceutical Co., Ltd. Stock

Equities

002317

CNE100000HW4

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-20 pm EDT 5-day change 1st Jan Change
14.41 CNY -0.96% Intraday chart for Guangdong Zhongsheng Pharmaceutical Co., Ltd. -3.48% -10.22%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 3.12B 431M Sales 2025 * 3.43B 474M Capitalization 12.22B 1.69B
Net income 2024 * 401M 55.39M Net income 2025 * 443M 61.2M EV / Sales 2024 * 3.92 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 3.56 x
P/E ratio 2024 *
30.7 x
P/E ratio 2025 *
27.7 x
Employees 1,732
Yield 2024 *
-
Yield 2025 *
-
Free-Float 71%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.96%
1 week-3.48%
Current month-5.01%
1 month+0.56%
3 months+12.58%
6 months-20.56%
Current year-10.22%
More quotes
1 week
14.34
Extreme 14.34
14.85
1 month
13.48
Extreme 13.48
15.57
Current year
10.22
Extreme 10.22
18.42
1 year
10.22
Extreme 10.22
21.66
3 years
8.08
Extreme 8.08
41.30
5 years
7.88
Extreme 7.88
41.30
10 years
7.54
Extreme 7.54
41.30
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 11-01-04
Director of Finance/CFO 52 10-02-07
Director/Board Member 35 18-12-05
Members of the board TitleAgeSince
Chief Executive Officer 54 11-01-04
Director/Board Member 56 10-02-07
Director/Board Member 42 16-12-28
More insiders
Date Price Change Volume
24-05-21 14.41 -0.96% 7,977,700
24-05-20 14.55 -0.61% 9,568,800
24-05-17 14.64 +1.67% 11,621,900
24-05-16 14.4 -0.96% 8,255,201
24-05-15 14.54 -2.61% 10,411,400

End-of-day quote Shenzhen S.E., May 20, 2024

More quotes
Guangdong Zhongsheng Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of medicines. The Company’s medicine products are categorized into Chinese patent medicines, chemical drugs, chemical bulk drugs and herbal decoction pieces, which include capsules for thrombus, pellets for upper respiratory tract diseases, granular for sunstroke, compound dexamethasone acetate creams and azelastine hydrochloride eye drops, among others. The Company distributes its products in domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
14.41
Average target price
-
Consensus
  1. Stock Market
  2. Equities
  3. 002317 Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW